Poster Presentation News Today

01.05.2024 - - Achieved $14.1 Million in Net Revenue from Sales of COSELA (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib ...

The Davis & Elkins College students who presented their research at the 14th Annual Kump Education Research Seminar at Kump Education Center Thursday demonstrat

Researchers in San Antonio loosely connected a deer-specific disease to the deaths of two hunters — which would be the first known cases of it jumping to humans. But there is more to the story.

In addition to a diverse offering of educational sessions and an engaging array of exhibitors across the show floor, this year’s NYSCC Suppliers’ Day conference will offer several special events, show staples, and activities to supplement attendees' networking experiences.

NGN-401 has been generally well-tolerated by three patients with multiple months of follow-up ...

Jacobin Pharma announced that the company will present the results of two preclinical evaluation of PARP7 inhibitor JAB-26766 and p53 Y220C reactivator JAB-30355 in form of the abstract during the...

SAN DIEGO & REHOVOT, Israel, April 04, 2024--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from a pilot study demonstrating the potential of a simple PCR assay based on EpiCheck® technology to accurately differentiate between small cell lung cancer (SCLC) subtypes. The Company is presenting the data in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, ...

/PRNewswire/ -- Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced its schedule of research...

MINNEAPOLIS, March 26, 2024 -- Panbela Therapeutics, Inc. , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today...

SAN DIEGO, Feb. 29, 2024 -- AnaptysBio, Inc. , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief...